Tuesday, August 9, 2016

New compound shows hope for prostate cancer therapy

Tetraaryl cyclobutane, or CB, is being studied as an option for prostate tumours that have grown resistant to current anti-androgen drugs, notably enzalutamide. Researchers have ide

from Health – The Indian Express http://bit.ly/2aWsJlK
via Food Channel Shows
from Tumblr http://bit.ly/2aIHI2R

No comments:

Post a Comment